Antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in Spain, 2004–2014

Cosgrove, 2006, The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs, Clin Infect Dis, 42, S82, 10.1086/499406 Patel, 2008, Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies, Infect Control Hosp Epidemiol, 29, 1099, 10.1086/592412 Rubio-Terrés, 2010, Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study, Clin Microbiol Infect, 16, 722, 10.1111/j.1469-0691.2009.02902.x European Centre for Disease Prevention and Control, 2011 European Centre for Disease Prevention and Control, 2012 European Centre for Disease Prevention and Control, 2013 Rodloff, 2008, Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the Tigecycline Evaluation and Surveillance Trial, Clin Microbiol Infect, 14, 307, 10.1111/j.1469-0691.2007.01943.x Aznar, 2012, Antimicrobial susceptibility among E. faecalis and E. faecium from France, Germany, Italy, Spain and the UK (T.E.S.T. Surveillance Study, 2004–2009), J Chemother, 24, 74, 10.1179/1120009X12Z.00000000016 Nørskov-Lauritsen, 2009, Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004–2007), Int J Antimicrob Agents, 34, 121, 10.1016/j.ijantimicag.2009.02.003 Denis, 2014, Antimicrobial susceptibility among Gram-positive and Gram-negative isolates collected in Europe between 2004 and 2010, J Glob Antimicrob Resist, 2, 155, 10.1016/j.jgar.2014.05.001 Cattoir, 2014, A longitudinal assessment of antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in France between 2004 and 2012, Antimicrob Resist Infect Control, 3, 36, 10.1186/2047-2994-3-36 Clinical and Laboratory Standards Institute, 2012 European Committee on Antimicrobial Susceptibility Testing, 2014 World Health Organization, 2014 Sánchez García, 2010, Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit, JAMA, 303, 2260, 10.1001/jama.2010.757 Morales, 2010, Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus, Clin Infect Dis, 50, 821, 10.1086/650574 Perez, 2007, Global challenge of multidrug-resistant Acinetobacter baumannii, Antimicrob Agents Chemother, 51, 3471, 10.1128/AAC.01464-06 del Mar Tomas, 2005, Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection, Clin Microbiol Infect, 11, 540, 10.1111/j.1469-0691.2005.01184.x Peleg, 2008, Acinetobacter baumannii: emergence of a successful pathogen, Clin Microbiol Rev, 21, 538, 10.1128/CMR.00058-07 Henwood, 2002, Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936), J Antimicrob Chemother, 49, 479, 10.1093/jac/49.3.479 Mezzatesta, 2008, In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy, Ann Clin Microbiol Antimicrob, 7, 4, 10.1186/1476-0711-7-4 Betriu, 2002, In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain, Antimicrob Agents Chemother, 46, 892, 10.1128/AAC.46.3.892-895.2002 Sánchez-Gómez, 2006, Linezolid-resistant Enterococcus faecalis: first report in Spain, J Chemother, 18, 440, 10.1179/joc.2006.18.4.440 Gómez-Gil, 2009, Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital, Diagn Microbiol Infect Dis, 65, 175, 10.1016/j.diagmicrobio.2009.06.010 Sánchez-Díaz, 2014, Emergence and long-lasting persistence of linezolid-resistant Enterococcus faecium-ST117 in an oncohematologic patient after a nine-day course of linezolid, Microb Drug Resist, 20, 17, 10.1089/mdr.2013.0034 Werner, 2008, Emergence and spread of vancomycin resistance among enterococci in Europe, Eur Surveill, 13, 47, 10.2807/ese.13.47.19046-en Díaz, 2009, Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006), Enferm Infecc Microbiol Clin, 27, 503, 10.1016/j.eimc.2008.09.006 Oteo, 2014, Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?, Enferm Infecc Microbiol Clin, 32, 17, 10.1016/S0213-005X(14)70170-3 Palacios-Baena, 2016, Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain, J Infect, 72, 152, 10.1016/j.jinf.2015.10.008 Betriu, 2006, Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study, Diagn Microbiol Infect Dis, 56, 437, 10.1016/j.diagmicrobio.2006.07.005 Hornsey, 2010, Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY–HasF efflux system also active against ciprofloxacin and cefpirome, J Antimicrob Chemother, 65, 479, 10.1093/jac/dkp475